middle.news
ImpediMed Names Erik Anderson CEO to Accelerate US Market Growth
1:24pm on Tuesday 7th of April, 2026 AEST
•
Healthcare
Read Story
ImpediMed Names Erik Anderson CEO to Accelerate US Market Growth
1:24pm on Tuesday 7th of April, 2026 AEST
Key Points
Erik Anderson appointed CEO/Managing Director to drive US growth
Focus on accelerating revenue and commercial execution for BCRL offering
Dr Parmjot Bains to support transition until 30 June 2026
Performance incentives linked to revenue, contract value, operating income, and cash flow
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Impedimed (ASX:IPD)
OPEN ARTICLE